Simultaneous Estimation of Metoprolol Succinate and Olmesartan Medoxomil in Pharmaceutical Formulation by Thin-Layer Chromatographic-Densitometric Method

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left" rowspan="2">Sample</td><td align="center" colspan="2">
										Correlation of center and slope spectra</td></tr><tr class="thead"><td align="center"><span style="width: 44px;"><svg height="13.45" id="M19" style="vertical-align:-2.21957pt" version="1.1" viewbox="0 0 44 13.45" width="44" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,13.45)">
<g transform="translate(72,-61.24)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑟</tspan>
<tspan style="font-size: 12.50px; " x="7.176722" y="0">(</tspan>
<tspan style="font-size: 12.50px; " x="11.340221" y="0">𝑠</tspan>
<tspan style="font-size: 12.50px; " x="16.841541" y="0">,</tspan>
<tspan style="font-size: 12.50px; " x="22.055292" y="0">𝑚</tspan>
<tspan style="font-size: 12.50px; " x="30.932423" y="0">)</tspan>
</text>
</g>
</g>
</svg></span></td><td align="center"><span style="width: 44.075001px;"><svg height="13.45" id="M20" style="vertical-align:-2.21957pt" version="1.1" viewbox="0 0 44.075001 13.45" width="44.075001" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,13.45)">
<g transform="translate(72,-61.24)">
<text transform="matrix(1,0,0,-1,-71.95,63.5)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑟</tspan>
<tspan style="font-size: 12.50px; " x="7.176722" y="0">(</tspan>
<tspan style="font-size: 12.50px; " x="11.340221" y="0">𝑚</tspan>
<tspan style="font-size: 12.50px; " x="20.217352" y="0">,</tspan>
<tspan style="font-size: 12.50px; " x="25.431103" y="0">𝑒</tspan>
<tspan style="font-size: 12.50px; " x="30.994938" y="0">)</tspan>
</text>
</g>
</g>
</svg></span></td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">MET</td><td align="center">0.991</td><td align="center">0.979</td></tr><tr><td align="left">MET capsule formulation A</td><td align="center">0.973</td><td align="center">0.969</td></tr><tr><td align="left">MET capsule formulation B</td><td align="center">0.985</td><td align="center">0.993</td></tr><tr><td align="left">OLM</td><td align="center">0.998</td><td align="center">0.928</td></tr><tr><td align="left">OLM capsule formulation A</td><td align="center">0.906</td><td align="center">0.936</td></tr><tr><td align="left">OLM capsule formulation B</td><td align="center">0.946</td><td align="center">0.954</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Peak purity correlation results of MET and OLM in two formulations at peak start, middle, and end.

International Scholarly Research Notices

tab1

Table 1

Table 1: Simultaneous Estimation of Metoprolol Succinate and Olmesartan Medoxomil in Pharmaceutical Formulation by Thin-Layer Chromatographic-Densitometric Method 

Table 1 | Simultaneous Estimation of Metoprolol Succinate and Olmesartan Medoxomil in Pharmaceutical Formulation by Thin-Layer Chromatographic-Densitometric Method 